FTC sues key pharmacy gain administrators above insulin selling prices The company brought motion in opposition to Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the checklist cost of lifestyle-preserving insulin medications. Insurers will carry on vertically integrating to keep extra profits in-dwelling, https://brookskgcaz.blogoxo.com/30759891/facts-about-healthcare-news-revealed